Bumrungrad Hospital PCL (BKK:BH)

Market Cap	157.01B +12.5%
Revenue (ttm)	25.66B +1.5%
Net Income	7.60B +2.0%
EPS	8.76 +2.1%
Shares Out	794.97M
PE Ratio	22.55
Forward PE	20.54
Dividend	5.00 (2.53%)
Ex-Dividend Date	Aug 28, 2026

Volume	3,032,128
Open	198.00
Previous Close	196.50
Day's Range	196.00 - 198.50
52-Week Range	136.00 - 214.00
Beta	0.17
Analysts	Buy
Price Target	216.17 (+9.45%)
Earnings Date	Nov 12, 2026

About Bumrungrad Hospital PCL

Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1975
• Employees: 3,253
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BH

Financial Performance

In 2025, Bumrungrad Hospital PCL's revenue was 25.45 billion, a decrease of -1.60% compared to the previous year's 25.86 billion. Earnings were 7.51 billion, a decrease of -3.38%.

Analyst Summary

According to 21 analysts, the average rating for BH stock is "Buy." The 12-month stock price target is ฿216.17, which is an increase of 9.45% from the latest price.

Price Target

฿216.17

(9.45% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error